Related Experiment Video
Updated: Jan 15, 2026

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
Nomogram for predicting acute kidney injury after primary PCI in STEMI patients: development and validation study
Ximin Li1, Juzhen Yan1, Yingji Chen1
1Department of Nephrology and Rheumatology, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, China.
Insights
This study identified risk factors for acute kidney injury (AKI) after percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction (STEMI) patients. A new nomogram model accurately predicts AKI risk, aiding early intervention strategies.
Area of Science:
- Cardiology
- Nephrology
- Medical Informatics
Background:
- Acute kidney injury (AKI) is a significant complication following percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction (STEMI) patients.
- Early identification of patients at high risk for AKI is crucial for implementing timely preventive measures.
Purpose of the Study:
- To identify independent risk factors for AKI after primary PCI in STEMI patients.
- To develop and validate a predictive nomogram model for post-PCI AKI.
Main Methods:
- Retrospective analysis of 227 STEMI patients undergoing primary PCI.
- Logistic regression for risk factor identification.
- Nomogram construction and evaluation using ROC, calibration curves, and DCA.
Main Results:
- 18.1% of patients developed AKI.
- Independent risk factors identified: NSAID use, female sex, elevated blood glucose, serum creatinine, and uric acid.
- The nomogram demonstrated superior predictive performance (AUC: 0.793) compared to the Mehran score (AUC: 0.626).
Conclusions:
- The developed nomogram is a valuable tool for accurately predicting AKI risk in STEMI patients post-PCI.
- The model facilitates early identification of high-risk individuals and supports stratified preventive strategies.
- High-risk patients experienced significantly longer hospital stays.
Objective:
To identify the risk factors for acute kidney injury (AKI) after primary percutaneous coronary intervention (PCI) in patients with ST-elevation myocardial infarction (STEMI) and to develop and evaluate a nomogram predictive model.
Methods:
A retrospective analysis was performed on STEMI patients who underwent primary PCI in our hospital between January 1, 2020, and December 31, 2024. Patients were divided into AKI and non-AKI groups. Univariate and multivariate logistic regression analyses were used to identify the independent risk factors for post-PCI AKI. Based on these factors, a nomogram model was constructed and its predictive accuracy, calibration, and clinical utility were assessed using receiver operating characteristic (ROC) curve analysis, calibration curves, and decision curve analysis (DCA).
Results:
A total of 227 STEMI patients were enrolled, of whom 41 (18.1%) developed AKI after PCI. NSAIDs use, female sex, blood glucose, serum creatinine, and serum uric acid emerged as independent risk factors. The ROC analysis showed that the nomogram model (AUC: 0.793) had superior predictive performance compared to the Mehran score (AUC: 0.626). Calibration plots showed strong alignment between predicted and observed outcomes, while DCA indicated a substantial net benefit. Moreover, patients in the high-risk group had significantly longer lengths of stays than those in the low- and moderate-risk groups.
Conclusion:
The nomogram model exhibits robust predictive accuracy and clinical utility, providing valuable support for the early identification of high-risk STEMI patients for AKI after primary PCI and facilitating the implementation of stratified preventive strategies.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Coronary Syndrome III: Diagnostic Studies
Acute Kidney Injury III: Clinical Manifestations

